Q00535 (CDK5_HUMAN) Homo sapiens (Human)

Cyclin-dependent kinase 5 UniProtKBInterProSTRINGInteractive Modelling

292 aa; Sequence (Fasta) ; (Isoform 2); 25 identical sequences

Available Structures

10 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structural mechanism for the inhibition of CD5-p25 from the roscovitine, aloisine and indirubin. Heteromer
Q15078;
1-292
99.66RRC;
Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin. Heteromer
Q15078;
1-292
99.65ALH;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1 Heteromer
Q15078;
2-291
100.065L; 10×EDO;PEG;CL;GOL;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 13 Heteromer
Q15078;
2-291
10063I;PGE;EDO;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7 Heteromer
Q15078;
2-291
10064V;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24 Heteromer
Q15078;
2-291
10061U;GOL; 17×EDO; 19×CL;
Crystal Structure of Cdk5:p25 in complex with an ATP analogue Heteromer
Q15078;
1-289
99.65
Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin. Heteromer
Q15078;
2-288
99.64IXM;
Structure and regulation of the CDK5-p25(nck5a) complex Heteromer
Q15078;
2-287
99.64
Crystal structure of compound 4a in complex with cdk5, showing an unusual binding mode to the hingeā€¦monomer2-289
100.0SO4;Z3R;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7vdq.1.Amonomer0.892-291
64V;100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23o0g.1.Amonomer0.821-257
99.62